Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by bionicjoeon Oct 08, 2018 11:58am
57 Views
Post# 28762079

RE:RE:Very thin trading Canada Closed...

RE:RE:Very thin trading Canada Closed...LaserStock29, with the results of the PP you can forget diving into any new research projects for the time being. You're just torturing yourself and other shareholders with your unrealistic fantasies. They have no money. How much plainer can I make that to you? What little cash they grossed from the PP will be used to finish the regulatory requirements of the NMIBC trial, pay off previous research commitments and take care of salaries with salaries probably taking the biggest budget hit. I hate to say it but some of the money could be siphoned off to keep the laser division operational though that might be marginal if they are using the cash derived from laser parts inventory to help with the day to day expenses. Just use up what you have and don't restock.

Until they refill the cash cupboards they'll be in hunker down conserve cash mode with no new expenditures allowed apart from office supplies. How soon that is is anybody's guess but it would help if the company were to inform the market that they have other irons in the fire that they can access to raise the money needed.
Bullboard Posts